Pneumonectomy for Lung Metastases:
Report of Ten Cases

Abstract

Today, pulmonary resection for lung metastases is a widely accepted treatment if complete resection can be achieved. However, 5-year survival is only 40 %. Many patients develop recurrences, but some reports have demonstrated that salvage operations can result in a long-term survival. A resection of a complete lung or a resection of more than a lung is still controversial since procedure-related morbidity or mortality does not outweigh the survival benefit. We report on a series of 10 consecutive patients who underwent a primary pneumonectomy or an operation on the residual lung after pneumonectomy with curative intent for pulmonary metastases. 5 year survival rates for the 10 patients after pneumonectomy alone or with additional resection was 45 %, which was not significantly different from those who underwent a more minor resection with a 5-year survival of 39 % (p = 0.40). Since there is currently no alternative proven therapy for patients with isolated pulmonary metastases, a primary or completion pneumonectomy may be offered to selected patients as long as sufficient pulmonary reserve is present, and a complete resection can be achieved.

Lung metastases - thoracic surgery - pneumonectomy

References

• 1 McCormack P, Bains M, Beattie E, Martini N. Pulmonary resection in metastatic carcinoma.  Chest. 1978;  73 163-166
• 2 Pastorino U, Buyse M, Friedel G. et al . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry for Lung Metastases.  J Thorac Cardiovasc Surg. 1997;  113 37-49
• 3 Hendriks J M, Romijn S, van Putte B. et al . Long-term results of surgical resection of lung metastases.  Acta Chir Belg. 2001;  101 267-272
• 4 Pogrebniak H, Roth J, Steinberg S, Rosenberg S, Pass H. Reoperative pulmonary resection in patients with soft tissue sarcoma.  Ann Thorac Surg. 1991;  52 197-203
• 5 Casson A G, Putnam J B, Natarajan G. et al . Efficacy of pulmonary metastasectomy for recurrent soft tissue sarcoma.  J Surg Oncol. 1991;  47 1-4
• 6 Hendriks J M, van Schil P E, Schrijvers D. Bilateral pulmonary resection for lung metastases: report of two cases.  Eur J Surg Oncol. 1999;  25 552-553
• 7 Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer.  J Thorac Cardiovasc Surg. 1978;  76 832-839
• 8 Me G overn, Trastek V, Pairolero P, Payne W. Completion pneumonectomy: indications, complications and results.  Ann Thorac Surg. 1988;  46 141-146
• 9 Putnam J. Douglas M, Natarajan G. Roth J. Extended resection of pulmonary metastases: is the risk justified?.  Ann Thorac Surg. 1993;  55 1440-1446
• 10 Al-Kattan K, Goldstraw P. Completion pneumonectomy: indications and outcome.  J Thorac Cardiovasc Surg. 1995;  110 1125-1129
• 11 Spaggiari L, Grunenwald H, Gerard Ph, Solli P, Le Chevalier Th. Pneumonectomy for lung metastases: indications, risks, and outcome.  Ann Thorac Surg. 1998;  66 1930-1933
• 12 Koong H, Pastorino U, Ginsberg R. for the International Registry of Lung Metastases . Is there a role for pneumonectomy in pulmonary metastases?.  Ann Thorac Surg. 1999;  68 2039-2043
• 13 Bernard A, Deschamps C, Allen M. et al . Pneumonectomy for malignant disease: factors affecting early morbidity and mortality.  J Thorac Cardiovasc Surg. 2001;  121 1076-1082
• 14 van Geel A, Pastorino U, Jauch K. et al . Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients.  Cancer. 1996;  77 675-682
• 15 Kandioler D, Kromer E, Tuchler H. et al . Long-term results after repeated surgical removal of pulmonary metastases.  Ann Thorac Surg. 1998;  65 909-912
• 16 Jaklitsch M, Mery C, Lukanich J. et al . Sequential thoracic metastasectomy prolongs survival by reestablishing local control within the chest.  J Thorac Cardiovasc Surg. 2001;  121 657-667
• 17 Grunenwald D, Spaggiari L, Girard P h. Baldeyrou P, Filaire M, Dennewald G. Completion pneumonectomy for lung metastases: is it justified?.  Eur J Cardiothorac Surg. 1997;  12 694-697
• 18 Weksler B, Burt M. Isolated lung perfusion with antineoplastic agents for pulmonary metastases. In: Faber LP, McCormack PM eds. Chest Surgery Clinics of North America. Metastatic disease to the lung. Pennsylvania: W.B.  Saunders. 1998;  8 157-182
• 19 Hendriks J M. Pulmonary metastases. Therapeutic Application of Isolated Lung Perfusion. PhD Thesis, Antwerp University 2001
• 20 Burt M, Liu D, Abolhoda A. et al . Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial.  Ann Thorac Surg. 2000;  69 1542-1549